The Homophilic Binding of Junctional Adhesion Molecule-C Mediates Tumor Cell-Endothelial Cell Interactions*

The junctional adhesion molecule C (JAM-C) was recently shown to undergo a heterophilic interaction with the leukocyte β2 integrin Mac-1, thereby mediating interactions between vascular cells in inflammatory cell recruitment. Here, the homophilic interaction of JAM-C is presented and functionally characterized to mediate tumor cell-endothelial cell interactions. Recombinant soluble JAM-C in fluid phase bound to immobilized JAM-C as assessed in a purified system; moreover, JAM-C-transfected Chinese hamster ovary (CHO) cells adhered to immobilized JAM-C. The homophilic interaction of JAM-C was mediated by the isolated amino-terminal Ig domain (D1), but not the carboxyl-terminal Ig domain (D2), of the molecule. Dimerization of JAM-A is dependent on the sequence RVE in the amino-terminal Ig domain. This motif is conserved in JAM-C (Arg64-Ile65-Glu66), and a single amino acid mutation in this motif (E66R) abolished the homophilic interaction of JAM-C. The lung carcinoma cell line NCI-H522 was found to express JAM-C. NCI-H522 cells adhered to immobilized JAM-C, as well as to JAM-C-transfected CHO cells, but not to mock-transfected CHO cells or to CHO cells transfected with the JAM-C mutant (E66R). Adhesion of NCI-H522 cells to JAM-C protein or JAM-C-transfected CHO cells was abolished in the presence of soluble JAM-C or the isolated D1. Furthermore, the adhesion of NCI-H522 cells to endothelial cells was significantly blocked by soluble JAM-C or the isolated D1. Thus, JAM-C undergoes a homophilic interaction via the Arg64-Ile65-Glu66 motif on the membrane-distal Ig domain of the molecule. The homophilic interaction of JAM-C can mediate tumor cell-endothelial cell interactions and may thereby be involved in the process of tumor cell metastasis.

[1]  S. Cunningham,et al.  JAM2 interacts with alpha4beta1. Facilitation by JAM3. , 2002, The Journal of biological chemistry.

[2]  E. Dejana,et al.  Homophilic Interaction of Junctional Adhesion Molecule* , 2000, The Journal of Biological Chemistry.

[3]  K. Zen,et al.  JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. , 2004, Molecular biology of the cell.

[4]  M. Aurrand-Lions,et al.  Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. , 2002, Blood.

[5]  H. Gabbert,et al.  Mechanisms of tumor metastasis: cell biological aspects and clinical implications , 2000, Journal of Cancer Research and Clinical Oncology.

[6]  G. Bazzoni.  The JAM family of junctional adhesion molecules. , 2003, Current opinion in cell biology.

[7]  S. Butz,et al.  The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity , 2003, Journal of Cell Science.

[8]  E. Dejana,et al.  Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration , 1998, The Journal of cell biology.

[9]  N. Matsuura,et al.  Increased expression of integrin α3β1 in highly brain metastatic subclone of a human non‐small cell lung cancer cell line , 2004 .

[10]  A. Remuzzi,et al.  Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. , 1993, The Journal of clinical investigation.

[11]  R. Aster,et al.  A recombinant soluble form of the integrin alpha IIb beta 3 (GPIIb-IIIa) assumes an active, ligand-binding conformation and is recognized by GPIIb-IIIa-specific monoclonal, allo-, auto-, and drug-dependent platelet antibodies. , 1998, Blood.

[12]  K. Preissner,et al.  Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle , 2003, Thrombosis and Haemostasis.

[13]  D. Vestweber,et al.  Junctional adhesion molecules (JAMs): more molecules with dual functions? , 2004, Journal of Cell Science.

[14]  A. Zernecke,et al.  JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes , 2002, Nature Immunology.

[15]  K. Preissner,et al.  The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins , 2003, The Journal of experimental medicine.

[16]  K. Preissner,et al.  The Junctional Adhesion Molecule-C Promotes Neutrophil Transendothelial Migration in Vitro and in Vivo* , 2004, Journal of Biological Chemistry.

[17]  U. Naik,et al.  Activation of human platelets by a stimulatory monoclonal antibody. , 1990, The Journal of biological chemistry.

[18]  P. Nawroth,et al.  The role of junctional adhesion molecules in cell-cell interactions. , 2005, Histology and histopathology.

[19]  J. Weinstein,et al.  Karyotypic complexity of the NCI-60 drug-screening panel. , 2003, Cancer research.

[20]  F. Winkler,et al.  X‐ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif , 2001, The EMBO journal.

[21]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[22]  S. Walsh,et al.  Human junction adhesion molecule regulates tight junction resealing in epithelia. , 2000, Journal of cell science.

[23]  J. Hartwig,et al.  Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation. , 2000, Blood.

[24]  M. Hendrix,et al.  Molecular Role(s) for Integrins in Human Melanoma Invasion , 2004, Cancer and Metastasis Reviews.

[25]  M. Aurrand-Lions,et al.  Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. , 2001, Blood.

[26]  M. Aurrand-Lions,et al.  JAM-2, a Novel Immunoglobulin Superfamily Molecule, Expressed by Endothelial and Lymphatic Cells* , 2001, The Journal of Biological Chemistry.